Genmab — December 2019
-
En brat stigning på 7 kr. på 5b minutter. Tak E L.
-
5 minutter
-
kongetal fra usa!
-
Det løftede markederne generelt i de minutter.
-
Sorry E L.
-
Det er helt rigtigt.
-
interestingly, InnovaTV 205 adds another arm, TV monotherapy. Adds 30 patients https://clinicaltrials.gov/ct2/history/NCT03786081?A=6&B=7&C=merged#StudyPageTop
-
Det gjorde det. Mange aktier og indeks havde det samme løft på det tidspunkt.
-
Multiple Myeloma Hub
@MM_Hub
Tomorrow is the official start of #ASH19! We want to know what content you are most looking forward to seeing from the @MM_Hub
during the meeting
https://twitter.com/MM_Hub/status/1202993896248225792 -
Vincent Rajkumar
@VincentRK
·
1 t
Ofatumumab maintenance in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study | Blood Cancer Journal #BCJhttps://www.nature.com/articles/s41408-019-0260-2 -
God morgen.
-
Janssen Announces BCMA CAR-T Therapy JNJ-4528 Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Relapsed or Refractory Multiple Myeloma https://www.prnewswire.com/news-releases/janssen-announces-bcma-car-t-therapy-jnj-4528-granted-us-fda-breakthrough-therapy-designation-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma-300970825.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind